The primary criterion is body mass index (BMI) , with most medications approved for adults with a BMI of 30 kg/m or greater (obesity), or 27 kg/m or greater (overweight) in the presence of at least one weight-related comorbidity
This includes telling the pancreas to release insulin after eating and signaling the liver to lower the amount of glucose it's making
With pre-reconstituted cartridges, this pen eliminates the need for mixing or measuring, ensuring accurate dosing and minimizing the risk of errors
Nearly double
The post says both Ozempic and standalone semaglutide activate the same GLP-1 receptor at the pancreas, gut, and brain, so administering two identical-mechanism drugs compounds the effects without additive benefit
We are very grateful to all the other people that have very kindly contributed through individual donations to support this research, in particular: Andrea Barbarossa